Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The FDA initially approved semaglutide for chronic weight management in patients with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition
Shop now at Nutrition Warehouse
Who Does NOT Use the Bridge The Bridge covers GLP-1 medications for the weight loss indication only
What BVC Express Includes: Medication Access Youll have access to compounded GLP-1 medications prescribed and managed by our clinical team
For people who need clinically proven interventions for obesity or metabolic disease, prescription medications remain the gold standard with the strongest evidence base
US$ 26.82
US$ 28.66
US$ 26.62
